Myriad Genetics Inc (MYGN) — Cash Flow Quality Index
Myriad Genetics Inc (MYGN) has a Cash Flow Quality Index of -1.60x as of September 2021. Operating cash flow of $-39.30 Million is below net income of $24.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Myriad Genetics Inc (MYGN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Myriad Genetics Inc Cash Flow Quality Index (2008–2020)
Historical Cash Flow Quality Index for Myriad Genetics Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Myriad Genetics Inc cash conversion from operations.
Annual Cash Flow Quality Index for Myriad Genetics Inc (2008–2020)
Year-by-year earnings quality comparison for Myriad Genetics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 18.20x | $83.70 Million | $4.60 Million | ▲ +0.0% |
| 2019 | 18.20x | $83.70 Million | $4.60 Million | ▲ +1992.7% |
| 2018 | 0.87x | $115.90 Million | $133.30 Million | ▼ -85.8% |
| 2017 | 6.10x | $106.20 Million | $17.40 Million | ▲ +330.1% |
| 2016 | 1.42x | $166.30 Million | $117.20 Million | ▼ -19.0% |
| 2015 | 1.75x | $140.50 Million | $80.20 Million | ▲ +62.3% |
| 2014 | 1.08x | $190.20 Million | $176.20 Million | ▼ -8.6% |
| 2013 | 1.18x | $173.90 Million | $147.20 Million | ▼ -6.6% |
| 2012 | 1.26x | $141.80 Million | $112.15 Million | ▼ -2.7% |
| 2011 | 1.30x | $130.83 Million | $100.71 Million | ▲ +27.6% |
| 2010 | 1.02x | $155.09 Million | $152.30 Million | ▲ +2.5% |
| 2009 | 0.99x | $84.04 Million | $84.61 Million | ▼ -54.2% |
| 2008 | 2.17x | $103.74 Million | $47.84 Million | — |